SCHEMBL24865976

SCHEMBL24865976

CC(C)CN1CCN(CCC2CCN(C)CC2)CC12CC2

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.32
ACHE P22303 1/20 0.31
SIGMAR1 Q99720 5/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26141959 0.89 HRH3 (0.33)
SCHEMBL24941817 0.87
SCHEMBL25101610 0.84 HRH3 (0.32) SIGMAR1
SCHEMBL24940836 0.78 HRH3 (0.31)
SCHEMBL25102016 0.77 HRH3 (0.33) SIGMAR1
SCHEMBL24940841 0.74 HRH3 (0.33) SIGMAR1
SCHEMBL25800650 0.73 HSD11B1 (0.31)
SCHEMBL25089862 0.72 HRH3 (0.32) SIGMAR1
SCHEMBL26329778 0.71 HRH3 (0.32) SIGMAR1
SCHEMBL14081460 0.69 NCF1 (0.50) NCF1ACHESIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023283263-A1 CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME FOGHORN THERAPEUTICS INC. (US) 2023-01-12 WO disclosed